Toward a neurobiology of psychotherapy: Basic science and clinical applications

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 2, 2005, Pages 145-158

  Etkin, Amit ^b   Pittenger, Christopher ^b   Polan, H Jonathan ^b   Kandel, Eric R ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; COGNITION; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; NEUROIMAGING; NEUROSCIENCE; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; TREATMENT OUTCOME; CONSCIOUSNESS; DIAGNOSTIC IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CONSCIOUSNESS; DIAGNOSTIC IMAGING; HUMANS; MENTAL DISORDERS; NEUROBIOLOGY; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 85047691125     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.2.145     Document Type: Review

References (64)

1. Ressler KJ, Rothbaum BO, Tannenbaum L, et al: Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61(11):1136-1144
2. Elkin I, Shea MT, Watkins JT, et al.: National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46(11):971-982
3. March J, Silva S, Petrycki S, et al: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Jama 2004; 292(7):807-820
4. Rector NA: Cognitive behavioural therapy reduces short term rehospitalisation compared with psychoeducation in inpatients with schizophrenia. Evid Based Ment Health 2005; 8(1):8
5. Kandel ER: Psychotherapy and the single synapse. The impact of psychiatric thought on neurobiologic research. N Engl J Med 1979; 301(19):1028-1037
6. Baxter LR, Jr., Schwartz JM, Bergman KS, et al.: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49(9):681-689
7. Brody AL, Saxena S, Schwartz JM, et al: FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 1998; 84(1):1-6
8. Brody AL, Saxena S, Stoessel P, et al: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58(7):631-640
9. Martin SD, Martin E, Rai SS, et al: Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58(7):641-648
10. Schwartz JM, Stoessel PW, Baxter LR, Jr., et al: Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53(2):109-113
11. Drevets WC: Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49:341-361
12. Kennedy SH, Javanmard M, Vaccarino FJ: A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can J Psychiatry 1997; 42(5):467-475
13. Mayberg HS: Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997; 9(3):471-481
14. Mayberg HS, Liotti M, Brannan SK, et al: Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156(5):675-682
15. Goldapple K, Segal Z, Garson C, et al: Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61(1):34-41
16. Furmark T, Tillfors M, Marteinsdottir I, et al: Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002; 59(5):425-433
17. Paquette V, Levesque J, Mensour B, et al: Change the mind and you change the brain: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003; 18(2):401-409
18. Tillfors M, Furmark T, Marteinsdottir I, et al: Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry 2001; 158(8):1220-1226
19. Meyer-Lindenberg A, Poline JB, Kohn PD, et al: Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 2001; 158(11):1809-1817
20. Mayberg HS, Brannan SK, Mahurin RK, et al: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8(4):1057-1061
21. Saxena S, Brody AL, Ho ML, et al: Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003; 160(3):522-532
22. Volk SA, Kaendler SH, Hertel A, et al: Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res 1997; 75(2):67-74
23. Wu J, Buchsbaum MS, Gillin JC, et al: Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999; 156(8):1149-1158
24. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al: Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158(3):405-415
25. Davidson RJ, Irwin W, Anderle MJ, et al: The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160(1):64-75
26. Bush G, Luu P, Posner MI: Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4(6):215-222
27. Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118 (Pt 1):279-306
28. Davidson RJ, Pizzagalli D, Nitschke JB, et al: Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002; 53:545-574
29. Drevets WC: Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001; 11(2):240-249
30. Whalen PJ, Bush G, McNally RJ, et al: The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 1998; 44(12):1219-1228
31. Kerns JG, Cohen JD, MacDonald AW, 3rd, et al: Anterior cingulate conflict monitoring and adjustments in control. Science 2004; 303(5660):1023-6
32. McGuire PK, Bench CJ, Frith CD, et al: Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994; 164(4):459-68
33. Rauch SL, Jenike MA, Alpert NM, et al: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51(1):62-70
34. Saxena S, Brody AL, Maidment KM, et al.: Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999; 21(6):683-93
35. Horn NR, Dolan M, Elliott R, et 1: Response inhibition and impulsivity: an fMRI study. Neuropsychologia 2003; 41(14):1959-66
36. Lubman DI, Yucel M, Pantelis C: Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction 2004; 99(12):1491-502
37. Beck AT, Clark DA: An information processing model of anxiety: automatic and strategic processes. Behav Res Ther 1997; 35(1):49-58
38. Gabbard GO: Basic principles of dynamic psychiatry. Washington, DC, American Psychiatric Press, Inc., 2000
39. Wong PS: Anxiety, signal anxiety, and unconscious anticipation: neuroscientific evidence for an unconscious signal function in humans. J Am Psychoanal Assoc 1999; 47(3):817-41
40. Etkin A, Klemenhagen KC, Dudman JT, et al: Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 2004; 44(6):1043-55
41. Aggleton JP: The amygdala: a functional analysis. New York (USA), Oxford University Press, 2000
42. Ekman P, Sorenson ER, Friesen WV: Pan-cultural elements in facial displays of emotion. Science 1969; 164(875):86-88
43. Mogg K, Bradley BP: A cognitive-motivational analysis of anxiety. Behav Res Ther 1998; 36(9):809-48
44. Hull AM: Neuroimaging findings in post-traumatic stress disorder. Systematic review. Br J Psychiatry 2002; 181:102-110
45. Rauch SL, Whalen PJ, Shin LM, et al: Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000; 47(9):769-776
46. Shin LM, Wright CI, Cannistraro PA, et al: A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005; 62(3):273-281
47. Kagan J, Reznick JS, Snidman N: The physiology and psychology of behavioral inhibition in children. Child Dev 1987; 58(6):1459-1473
48. Emde RN, Plomin R, Robinson JA, et al: Temperament, emotion, and cognition at fourteen months: the MacArthur Longitudinal Twin Study. Child Dev 1992; 63(6):1437-1455
49. Schwartz CE, Wright CI, Shin LM, et al: Inhibited and uninhibited infants grown up: adult amygdalar response to novelty. Science 2003; 300(5627):1952-1953
50. Hirshfeld-Becker DR, Biederman J, Calltharp S, et al: Behavioral inhibition and disinhibition as hypothesized precursors to psychopathology: implications for pediatric bipolar disorder. Biol Psychiatry 2003; 53(11):985-99
51. Battaglia M, Ogliari A, Zanoni A, et al: Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions. Arch Gen Psychiatry 2005; 62(1):85-94
52. Biederman J, Hirshfeld-Becker DR, Rosenbaum JF, et al: Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry 2001; 158(10):1673-1679
53. Pollack MH: Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry 2001; 62 Suppl 12:24-29
54. APA: Diagnostic and statistical manual of mental disorders DSM-IV-TR. Washington, DC, American Psychiatric Press, Inc., 2000
55. Battaglia M, Ogliari A, Zanoni A, et al: Children's discrimination of expressions of emotions: relationship with indices of social anxiety and shyness. J Am Acad Child Adolesc Psychiatry 2004; 43(3):358-365
56. Stein MB, Goldin PR, Sareen J, et al: Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002; 59(11):1027-1034
57. Fox NA, Henderson HA, Marshall PJ, et al: Behavioral inhibition: linking biology and behavior within a developmental framework. Annu Rev Psychol 2005; 56:235-262
58. Nachmias M, Gunnar M, Mangelsdorf S, et al: Behavioral inhibition and stress reactivity: the moderating role of attachment security. Child Dev 1996; 67(2):508-522
59. Rubin KH, Burgess KB, Hastings PD: Stability and social-behavioral consequences of toddlers' inhibited temperament and parenting behaviors. Child Dev 2002; 73(2);483-495
60. Liebowitz MR, Gelenberg AJ, Munjack D: Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry 2005; 62(2):190-198
61. Westenberg HG, Liebowitz MR: Overview of panic and social anxiety disorders. J Clin Psychiatry 2004; 65 Suppl 14:22-26
62. Fisher PH, Masia-Warner C, Klein RG: Skills for social and academic success: a school-based intervention for social anxiety disorder in adolescents. Clin Child Fam Psychol Rev 2004; 7(4):241-249
63. Fox E, Russo R, Dutton K: Attentional bias for threat: evidence for delayed disengagement from emotional faces. Cogn emot 2002; 16(3):355-379
64. Derryberry D, Reed MA: Anxiety-related attentional biases and their regulation by attentional control. J Abnorm Psychol 2002; 111(2):225-236